Literature DB >> 1714519

Fine specificity of cellular immune responses in humans to human cytomegalovirus immediate-early 1 protein.

N J Alp1, T D Allport, J Van Zanten, B Rodgers, J G Sissons, L K Borysiewicz.   

Abstract

Cell-mediated immunity is important in maintaining the virus-host equilibrium in persistent human cytomegalovirus (HCMV) infection. The HCMV 72-kDa major immediate early 1 protein (IE1) is a target for CD8+ cytotoxic T cells in humans, as is the equivalent 89-kDa protein in mouse. Less is known about responses against this protein by CD4+ T cells, which may be important as direct effector cells or helper cells for antibody and CD8+ responses. Proliferative-T-cell responses to HCMV IE1 were studied in normal seropositive subjects. Peripheral blood mononuclear cells from 85% of seropositive subjects proliferated in response to HCMV from infected fibroblasts, and of these, 73% responded to recombinant baculovirus IE1. Responding cells were predominantly CD3+ CD4+. IE1 antigen preparations, including baculovirus recombinant protein, transfected rat cell nuclei, and synthetic peptides, induced IE1-specific T-cell lines which cross-reacted between the preparations. The fine specificity of these IE1-specific T-cell lines was studied by using overlapping synthetic peptides encompassing the entire sequence of the IE1 protein. The regions of the IE1 molecule recognized were identified and these varied between individuals, possibly reflecting differences in major histocompatibility complex (MHC) class II haplotype. In one subject, the peptide specificities of proliferative and MHC class I-restricted cytotoxic determinants on IE1 were spatially distinct. Thus, no single immunodominant T-cell determinant within HCMV IE1 was identified, suggesting that multiple peptides or a region of the 72-kDa IE1 protein would be required to induce specific T-cell responses in humans.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1714519      PMCID: PMC248939     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  Vaccination and protection from a lethal viral infection: identification, incorporation, and use of a cytotoxic T lymphocyte glycoprotein epitope.

Authors:  L S Klavinskis; J L Whitton; E Joly; M B Oldstone
Journal:  Virology       Date:  1990-10       Impact factor: 3.616

2.  High frequency of memory and effector gag specific cytotoxic T lymphocytes in HIV seropositive individuals.

Authors:  F M Gotch; D F Nixon; N Alp; A J McMichael; L K Borysiewicz
Journal:  Int Immunol       Date:  1990       Impact factor: 4.823

3.  The structure of the major immediate early gene of human cytomegalovirus strain AD169.

Authors:  A Akrigg; G W Wilkinson; J D Oram
Journal:  Virus Res       Date:  1985-03       Impact factor: 3.303

4.  Autoregulation of the human cytomegalovirus major immediate-early gene.

Authors:  R M Stenberg; M F Stinski
Journal:  J Virol       Date:  1985-12       Impact factor: 5.103

5.  Development of a competitive enzyme-linked immunosorbent assay for detecting cytomegalovirus antibody.

Authors:  T G Wreghitt; J Hicks; J J Gray; C O'Connor
Journal:  J Med Virol       Date:  1986-02       Impact factor: 2.327

Review 6.  Genetic and molecular basis for T- and B-cell recognition of hepatitis B viral antigens.

Authors:  D R Milich
Journal:  Immunol Rev       Date:  1987-10       Impact factor: 12.988

7.  Establishment of a rat cell line inducible for the expression of human cytomegalovirus immediate-early gene products by protein synthesis inhibition.

Authors:  R Boom; J L Geelen; C J Sol; A K Raap; R P Minnaar; B P Klaver; J van der Noordaa
Journal:  J Virol       Date:  1986-06       Impact factor: 5.103

8.  Molecular basis for cytolytic T-lymphocyte recognition of the murine cytomegalovirus immediate-early protein pp89.

Authors:  M Del Val; H Volkmer; J B Rothbard; S Jonjić; M Messerle; J Schickedanz; M J Reddehase; U H Koszinowski
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

9.  Identification of the human cytomegalovirus glycoprotein B gene and induction of neutralizing antibodies via its expression in recombinant vaccinia virus.

Authors:  M P Cranage; T Kouzarides; A T Bankier; S Satchwell; K Weston; P Tomlinson; B Barrell; H Hart; S E Bell; A C Minson
Journal:  EMBO J       Date:  1986-11       Impact factor: 11.598

10.  A nonstructural polypeptide encoded by immediate-early transcription unit 1 of murine cytomegalovirus is recognized by cytolytic T lymphocytes.

Authors:  U H Koszinowski; G M Keil; H Schwarz; J Schickedanz; M J Reddehase
Journal:  J Exp Med       Date:  1987-07-01       Impact factor: 14.307

View more
  19 in total

1.  The essential role of guinea pig cytomegalovirus (GPCMV) IE1 and IE2 homologs in viral replication and IE1-mediated ND10 targeting.

Authors:  Julia Hornig; K Yeon Choi; Alistair McGregor
Journal:  Virology       Date:  2017-02-10       Impact factor: 3.616

2.  The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL.

Authors:  M R Wills; A J Carmichael; K Mynard; X Jin; M P Weekes; B Plachter; J G Sissons
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

3.  Ex vivo stimulation and expansion of both CD4(+) and CD8(+) T cells from peripheral blood mononuclear cells of human cytomegalovirus-seropositive blood donors by using a soluble recombinant chimeric protein, IE1-pp65.

Authors:  J Vaz-Santiago; J Lulé; P Rohrlich; C Jacquier; N Gibert; E Le Roy; D Betbeder; J L Davignon; C Davrinche
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

4.  Escape of human cytomegalovirus from HLA-DR-restricted CD4(+) T-cell response is mediated by repression of gamma interferon-induced class II transactivator expression.

Authors:  E Le Roy; A Mühlethaler-Mottet; C Davrinche; B Mach; J L Davignon
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

5.  CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection.

Authors:  M Matloubian; R J Concepcion; R Ahmed
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

6.  The role of interferon beta in human cytomegalovirus-mediated inhibition of HLA DR induction on endothelial cells.

Authors:  D D Sedmak; S Chaiwiriyakul; D A Knight; W J Waldmann
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

7.  Anti-human cytomegalovirus activity of cytokines produced by CD4+ T-cell clones specifically activated by IE1 peptides in vitro.

Authors:  J L Davignon; P Castanié; J A Yorke; N Gautier; D Clément; C Davrinche
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

8.  Cytomegalovirus inhibits major histocompatibility class II expression on infected endothelial cells.

Authors:  D D Sedmak; A M Guglielmo; D A Knight; D J Birmingham; E H Huang; W J Waldman
Journal:  Am J Pathol       Date:  1994-04       Impact factor: 4.307

9.  Human cytomegalovirus-infected cells have unstable assembly of major histocompatibility complex class I complexes and are resistant to lysis by cytotoxic T lymphocytes.

Authors:  A P Warren; D H Ducroq; P J Lehner; L K Borysiewicz
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

10.  Cytomegalovirus-related sequence in an atypical cytopathic virus repeatedly isolated from a patient with chronic fatigue syndrome.

Authors:  W J Martin; L C Zeng; K Ahmed; M Roy
Journal:  Am J Pathol       Date:  1994-08       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.